Skip to main content
Erschienen in: Acta Neurologica Belgica 2/2018

07.11.2017 | Original Article

Quality of life in adult patients with limb–girdle muscular dystrophies

verfasst von: Marina Peric, Stojan Peric, Jelena Stevanovic, Sara Milovanovic, Ivana Basta, Ana Nikolic, Aleksandra Kacar, Vidosava Rakocevic-Stojanovic

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Although limb–girdle muscular dystrophies (LGMD) can cause permanent disability, to date there are no studies that examined quality of life (QoL) in these patients. Our aim was to evaluate QoL in patients with LGMD, and to identify the most significant predictors of QoL. The study comprised 46 patients with diagnosis of limb–girdle muscular weakness. QoL in patients was evaluated using two scales—SF-36 questionnaire and the Individualized Neuromuscular Quality of Life questionnaire (INQoL). Following scales were also applied: Epworth Sleepiness Scale (ESS), Hamilton Scale for Depression (HamD), and Krupp’s Fatigue Severity Scale (FSS). Mean SF-36 score was 52.4 ± 23.5, and physical composite score was worse than mental. Total INQoL score was 46.1 ± 20.4, with worst results obtained for weakness, fatigue and independence, while social relationships and emotions showed better results. Significant predictors of worse SF-36 score in LGMD patients were higher fatigue level (β = − 0.470, p < 0.01) and use of assistive device (β = − 0.245, p < 0.05). Significant predictors of worse INQoL score were higher fatigue level (β = 0.514, p < 0.01) and presence of cardiomyopathy (β = − 0.385, p < 0.01). It is of special interest that some of the identified factors that correlated with worse QoL in LGMD patients were amenable to treatment.
Literatur
1.
Zurück zum Zitat Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 33:1–12PubMedPubMedCentral Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 33:1–12PubMedPubMedCentral
2.
Zurück zum Zitat Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G et al (2014) Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 83:1453–1463CrossRefPubMedPubMedCentral Narayanaswami P, Weiss M, Selcen D, David W, Raynor E, Carter G et al (2014) Evidence-based guideline summary: diagnosis and treatment of limb-girdle and distal dystrophies: report of the guideline development subcommittee of the American Academy of Neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine. Neurology 83:1453–1463CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Mahmood AO, Mei JX (2014) Limb-girdle muscular dystrophies: where next after six decades from the first proposal (review). Mol Med Rep 9:1515–1532CrossRefPubMedPubMedCentral Mahmood AO, Mei JX (2014) Limb-girdle muscular dystrophies: where next after six decades from the first proposal (review). Mol Med Rep 9:1515–1532CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 14:1103–1109CrossRefPubMed Kleyweg RP, van der Meché FG, Schmitz PI (1991) Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain–Barré syndrome. Muscle Nerve 14:1103–1109CrossRefPubMed
5.
Zurück zum Zitat Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15:376–381CrossRefPubMed Johns MW (1992) Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 15:376–381CrossRefPubMed
7.
Zurück zum Zitat Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123CrossRefPubMed Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121–1123CrossRefPubMed
9.
Zurück zum Zitat Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR (2007) Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 68(13):1051–1057CrossRefPubMed Vincent KA, Carr AJ, Walburn J, Scott DL, Rose MR (2007) Construction and validation of a quality of life questionnaire for neuromuscular disease (INQoL). Neurology 68(13):1051–1057CrossRefPubMed
10.
Zurück zum Zitat Peric S, Rakocevic-Stojanovic V, Basta I, Peric M, Milicev M, Pavlovic S et al (2013) Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 115:270–275CrossRefPubMed Peric S, Rakocevic-Stojanovic V, Basta I, Peric M, Milicev M, Pavlovic S et al (2013) Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neurosurg 115:270–275CrossRefPubMed
11.
Zurück zum Zitat Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V et al (2016) Quality of life in patients with myotonic dystrophy type 2. J Neurol Sci 365:158–161CrossRefPubMed Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V et al (2016) Quality of life in patients with myotonic dystrophy type 2. J Neurol Sci 365:158–161CrossRefPubMed
12.
Zurück zum Zitat Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S et al (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38:181–185CrossRefPubMed Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S et al (2006) Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 38:181–185CrossRefPubMed
13.
Zurück zum Zitat Kalkman JS, Schillings ML, van der Werf SP, Padberg GW, Zwarts MJ, van Engelen BG et al (2005) Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 76:1406–1409CrossRefPubMedPubMedCentral Kalkman JS, Schillings ML, van der Werf SP, Padberg GW, Zwarts MJ, van Engelen BG et al (2005) Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosurg Psychiatry 76:1406–1409CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG (2011) High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol 258:1820–1826CrossRefPubMedPubMedCentral Tieleman AA, Jenks KM, Kalkman JS, Borm G, van Engelen BG (2011) High disease impact of myotonic dystrophy type 2 on physical and mental functioning. J Neurol 258:1820–1826CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36(3):294–306CrossRefPubMed Meola G, Sansone V (2007) Cerebral involvement in myotonic dystrophies. Muscle Nerve 36(3):294–306CrossRefPubMed
16.
Zurück zum Zitat Miladi N, Bourguignon JP, Hentati F (1999) Cognitive and psychological profile of a Tunisian population of limb girdle muscular dystrophy. Neuromuscul Disord 9(5):352–354CrossRefPubMed Miladi N, Bourguignon JP, Hentati F (1999) Cognitive and psychological profile of a Tunisian population of limb girdle muscular dystrophy. Neuromuscul Disord 9(5):352–354CrossRefPubMed
17.
Zurück zum Zitat Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V et al (2014) Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neuros 126:76–81CrossRef Rakocevic-Stojanovic V, Peric S, Madzarevic R, Dobricic V, Ralic V, Ilic V et al (2014) Significant impact of behavioral and cognitive impairment on quality of life in patients with myotonic dystrophy type 1. Clin Neurol Neuros 126:76–81CrossRef
18.
Zurück zum Zitat Peric S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V et al (2010) Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg 110:71–77PubMed Peric S, Rakocevic-Stojanovic V, Stevic Z, Basta I, Pavlovic S, Vujanac V et al (2010) Health-related quality of life in patients with myotonic dystrophy type 1 and amyotrophic lateral sclerosis. Acta Neurol Belg 110:71–77PubMed
19.
Zurück zum Zitat Winter Y, Schepelmann K, Spottke AE, Claus D, Grothe C, Schröder R et al (2010) Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257:1473–1481CrossRefPubMed Winter Y, Schepelmann K, Spottke AE, Claus D, Grothe C, Schröder R et al (2010) Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol 257:1473–1481CrossRefPubMed
20.
Zurück zum Zitat Peric S, Vujnic M, Dobricic V, Marjanovic A, Basta I, Novakovic I et al (2016) Five-year study of quality of life in myotonic dystrophy. Acta Neurol Scand 134(5):346–351CrossRefPubMed Peric S, Vujnic M, Dobricic V, Marjanovic A, Basta I, Novakovic I et al (2016) Five-year study of quality of life in myotonic dystrophy. Acta Neurol Scand 134(5):346–351CrossRefPubMed
21.
Zurück zum Zitat Youssof S (2016) The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy. Muscle Nerve 53(5):694–699CrossRefPubMedPubMedCentral Youssof S (2016) The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy. Muscle Nerve 53(5):694–699CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Sprangers MA, Schwartz CE (1999) Integrating response shift into health related quality of life research: a theoretical model. Soc Sci Med 48:1507–1515CrossRefPubMed Sprangers MA, Schwartz CE (1999) Integrating response shift into health related quality of life research: a theoretical model. Soc Sci Med 48:1507–1515CrossRefPubMed
23.
Zurück zum Zitat Laberge L, Mathieu J, Auclair J, Gagnon É, Noreau L, Gagnon C (2013) Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol 70(5–6):308–315CrossRefPubMed Laberge L, Mathieu J, Auclair J, Gagnon É, Noreau L, Gagnon C (2013) Clinical, psychosocial, and central correlates of quality of life in myotonic dystrophy type 1 patients. Eur Neurol 70(5–6):308–315CrossRefPubMed
24.
Zurück zum Zitat Steptoe A, Mohabir A, Mahon NG, McKenna WJ (2000) Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart 83:645–650CrossRefPubMedPubMedCentral Steptoe A, Mohabir A, Mahon NG, McKenna WJ (2000) Health related quality of life and psychological wellbeing in patients with dilated cardiomyopathy. Heart 83:645–650CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Magnusson P, Mörner S, Gadler F, Karlsson J (2016) Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators. Health Qual Life Outcomes 14:62CrossRefPubMedPubMedCentral Magnusson P, Mörner S, Gadler F, Karlsson J (2016) Health-related quality of life in hypertrophic cardiomyopathy patients with implantable defibrillators. Health Qual Life Outcomes 14:62CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C et al (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134(12):3530–3546CrossRefPubMed Minnerop M, Weber B, Schoene-Bake JC, Roeske S, Mirbach S, Anspach C et al (2011) The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain 134(12):3530–3546CrossRefPubMed
27.
Zurück zum Zitat van der Sluijs BM, Knoop H, Bleijenberg G, van Engelen BG, Voermans NC (2016) The Dutch patients’ perspective on oculopharyngeal muscular dystrophy: a questionnaire study on fatigue, pain and impairments. Neuromuscul Disord 26(3):221–226CrossRefPubMed van der Sluijs BM, Knoop H, Bleijenberg G, van Engelen BG, Voermans NC (2016) The Dutch patients’ perspective on oculopharyngeal muscular dystrophy: a questionnaire study on fatigue, pain and impairments. Neuromuscul Disord 26(3):221–226CrossRefPubMed
28.
Zurück zum Zitat Laberge L, Dauvilliers Y, Bégin P, Richer L, Jean S, Mathieu J (2009) Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Neuromuscul Disord 19(6):397–402CrossRefPubMed Laberge L, Dauvilliers Y, Bégin P, Richer L, Jean S, Mathieu J (2009) Fatigue and daytime sleepiness in patients with myotonic dystrophy type 1: to lump or split? Neuromuscul Disord 19(6):397–402CrossRefPubMed
29.
Zurück zum Zitat Krupp LB (2003) Fatigue. Butterworth Heinemann, Philadelphia Krupp LB (2003) Fatigue. Butterworth Heinemann, Philadelphia
30.
Zurück zum Zitat Lou JS, Weiss MD, Carter GT (2010) Assessment and management of fatigue in neuromuscular disease. Am J Hosp Palliat Med 27:145CrossRef Lou JS, Weiss MD, Carter GT (2010) Assessment and management of fatigue in neuromuscular disease. Am J Hosp Palliat Med 27:145CrossRef
Metadaten
Titel
Quality of life in adult patients with limb–girdle muscular dystrophies
verfasst von
Marina Peric
Stojan Peric
Jelena Stevanovic
Sara Milovanovic
Ivana Basta
Ana Nikolic
Aleksandra Kacar
Vidosava Rakocevic-Stojanovic
Publikationsdatum
07.11.2017
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2018
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-017-0857-9

Weitere Artikel der Ausgabe 2/2018

Acta Neurologica Belgica 2/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.